D-0149-2020 Class II Terminated

Recalled by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center — West Columbia, SC

FDA drug recall D-0149-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 9, 2019 and is designated Class II. Reason for recall: GMP Deviations: potential glass contamination The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 615 bags.

Recall details

Product Type
Drugs
Report Date
Oct 30, 2019
Initiation Date
Oct 9, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
615 bags

Product description

PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20

Reason for recall

GMP Deviations: potential glass contamination

Distribution pattern

Nationwide.

Code information

Lot: FR9002A Exp. 12/12/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0149-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0149-2020. Report a data issue: hello@regdatalab.com.